Draft Program

Program Co-Chairs
Demissie Alemayehu, Pfizer & David Madigan, Columbia

7:30 AM – 8:25 AM

  • Registration and Breakfast

8:25 AM – 8:30 AM

  • Welcome Address
  • David Madigan, Ph.D., Columbia University

8:30 Am – 9:00 AM

  • Opening Plenary Session (Chair D. Madigan)
  • Kannan Natarajan, Ph.D., Pfizer Inc.

9:00 AM – 10:00 Am

  • Keynote Address I (Chair K. Natarajan)
  • Amy P. Abernethy, MD, Ph.D
  • US Food and Drug Administration (FDA)

10:00 AM – 10:30 AM

  • Break

10:30 AM – 11:00 AM

  • Plenary Session I (Chair, D. Alemayehu, Pfizer Inc)
  • “ML and AI in Clinical Development and Statistical Innovation in AbbVie.”
  • Wang Li, Ph.D., AbbVie
  • Lawrence Carin, Ph.D. Duke University

11:00 – 11:30

  • Break

11:30 – 12:00

12:00 – 12:30

  • Plenary Session II (Chair TBD)
  • “Artificial Intelligence in Pharmaceutical R&D at AstraZeneca.” Faisal Khan, AstraZeneca
  • Noémie Elhadad, Ph.D., Columbia University

12:30 -1:00

  • Lunch

1:00 – 2:00

  • Keynote Address II (Chair D. Madigan)
  • Mihaela van der Schaar
  • University of Cambridge and UCLA

2:00 – 2:30

  • Break

2:30 – 3:00

  • Plenary Session III (Chair TBD)
  • Adler Perotte, Columbia University
  • Jesse A. Berlin, Johnson & Johnson

3:00 – 3:15

  • Break

3:15 – 4:50

  • Panel Discussion: “Ethical Issues with AI in Clinical Drug Development”
  • (Moderator, Jeannette M. Wing, Ph.D., Columbia University)
  • FDA
  • TBD
  • TBD

4:50 – 5:00

  • Closing Remarks and wrap-up
  • Demissie Alemayehu, Ph.D., Pfizer Inc